Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanthanum carbonate long-term extension in dialysis
NCT00150540Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2002
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of lanthanum carbonate in hyperphosphatemia, sponsored by Takeda. Started Oct 2002; status: completed.
02
Drugs
lanthanum carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00150540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150540.